+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
ID07905937

Observational Study on Brain Injury from Whole-Brain Radiotherapy Combined with PD-1 Inhibitors in Small Cell Lung Cancer

Led by Guizhou Medical University · Updated on 2026-10-30

42

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating brain injury caused by whole-brain radiotherapy combined with immunotherapy in patients with small cell lung cancer SCLC who are eligible for prophylactic cranial irradiation PCI. The study includes patients with limited-stage SCLC who have achieved a complete or partial remission after first-line treatment, and patients with extensive-stage SCLC whose tumors are effectively controlled after systemic therapy without clear brain metastases. The study aims to understand if adding whole-brain radiotherapy to immunotherapy increases neurological impairment. The study observes two groups one group with extensive-stage SCLC receiving first-line chemotherapy combined with PD-1 inhibitor immunotherapy followed by PCI after two cycles if responding and a control group with limited-stage SCLC receiving standard concurrent chemoradiotherapy followed by PCI after two cycles if responding. Starting after PCI, participants undergo brain contrast-enhanced MRI and chest and abdominal CT scans every three months. Treatment-related toxicity is evaluated using standardized criteria, and cognitive function is assessed regularly using MMSE and MoCA tests. Participants provide venous blood samples before radiotherapy and every three months afterward for various laboratory tests, including blood counts and organ function. Stool and urine tests are also performed periodically. The main outcome measured is progression-free survival from enrollment to the end of treatment at 12 months. The study carefully monitors neurological function and treatment side effects over time to evaluate the combined effect of whole-brain radiotherapy and immunotherapy on brain injury.

CONDITIONS

Brief Title

Exploration of Whole-Brain Radiotherapy Combined With PD-1 Inhibitors on Brain Injury

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here